Keywords: Sanofi-Aventis, Multaq, Bond offer
Sanofi-Aventis’ Multaq less effective than amiodarone, says US researchers, but firm still recommended by SEB analysts
Article | 09 April 2010
An article in the Journal of the American College of Cardiology has suggested that the use of French drug major ...
Enjoying this article? To continue reading you need to login or subscribe.